Collegium Pharmaceutical's Series B - II Round

Collegium Pharmaceutical raised a round of funding on October 02, 2013.

Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chron…

Articles about Collegium Pharmaceutical's Series B - II Round: